|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61K 31/454 | |||
| C07K 16/28 | |||
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2476438 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10815436.0 |
| Europos patento paraiškos padavimo data | 2010-09-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-07-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-07-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2010/065566 |
| Data | 2010-09-09 |
| (87) | Numeris | WO 2011/030841 |
| Data | 2011-03-17 |
| (30) | Numeris | Data | Šalis |
| 2009209218 | 2009-09-10 | JP | |
| 241558 P | 2009-09-11 | US |
| (72) |
ISHII, Toshihiko, JP
ASANO, Miyoko, JP
|
| (73) |
Kyowa Hakko Kirin Co., Ltd.,
1-6-1, Ohtemachi Chiyoda-ku, Tokyo 100-8185,
JP
|
| (54) | MEDICAMENT INCLUDING ANTIBODY COMPOSITION SPECIFICALLY BOUND TO HUMAN CC CHEMOKINE RECEPTOR 4 (CCR4) |
| MEDICAMENT INCLUDING ANTIBODY COMPOSITION SPECIFICALLY BOUND TO HUMAN CC CHEMOKINE RECEPTOR 4 (CCR4) |